This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Adrx, Inc.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: James Treanor: Innovator in Pharmaceutical Compositions
Introduction
James Treanor is a notable inventor based in Lake Sherwood, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide inhibitors for various medical applications. With a total of 2 patents, Treanor's work focuses on addressing critical health issues through innovative therapeutic solutions.
Latest Patents
Treanor's latest patents include groundbreaking inventions in the realm of tau aggregation peptide inhibitors and peptide inhibitors of transcription factor aggregation. The first patent relates to tau aggregation inhibitors, specifically targeting amyloid therapeutics. This invention provides pharmaceutical compositions and methods for treating conditions associated with tau aggregation using specific peptides. The second patent focuses on materials and methods to inhibit the aggregation of transcription factors, such as p53, p63, and p73 inhibitors. This invention is particularly relevant in the development of cancer chemotherapeutics, offering new avenues for treatment through specialized peptide compositions.
Career Highlights
James Treanor is currently associated with Adrx, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions that address complex medical challenges.
Collaborations
Treanor collaborates with talented individuals such as Shiho Tanaka and Ashley Wright, enhancing the scope and impact of his research initiatives. Their combined expertise fosters a collaborative environment that drives innovation in pharmaceutical development.
Conclusion
James Treanor's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his commitment to advancing medical science. His work in developing peptide inhibitors showcases the potential for innovative treatments in addressing serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile